Clinical Study Results
Did any adverse reactions happen during this study?
There were 15.0% of participants who had adverse reactions during the study that the
study doctors thought might be related to savolitinib. This was 3 out of 20 participants.
There were 50.0% of participants who had adverse reactions during the study that the
study doctors thought might be related to rifampicin. This was 9 out of 18 participants.
The table below shows how many participants had adverse reactions.
Adverse reactions during this study
Savolitinib Rifampicin
(out of 20 participants) (out of 18 participants)
How many participants had
15.0% (3) 50.0% (9)
adverse reactions?
How many participants left
this study due to adverse 5.0% (1) 0.0% (0)
reactions?
7